Dinnies Johannes von der Osten
Amministratore Delegato presso Elector GmbH
Provenienza dei contatti di primo grado di Dinnies Johannes von der Osten
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
| Public Company | Biotechnology | 21 | |
GoodVent Beteiligungsmanagement GmbH & Co. KG
 GoodVent Beteiligungsmanagement GmbH & Co. KG Investment ManagersFinance GoodVent Beteiligungsmanagement GmbH & Co. KG is a private equity firm located in Magdeburg in the central-eastern part of Germany. The firm originated in 2000 to take over the business of the pre-existing investment arm of Land Sachsen-Anhalt. Previously known as IBG Beteiligungsgesellschaft Sachsen-Anhalt mbH, the firm was privatized in 2007, and was briefly renamed Acceres Beteiligungsmanagement GmbH & Co. KG. GoodVent manages the IBG venture capital funds.
13
| Extinct | Investment Managers | 13 |
IBG Beteiligungsgesellschaft Sachsen-Anhalt mbH
 IBG Beteiligungsgesellschaft Sachsen-Anhalt mbH Investment ManagersFinance Beteiligungsgesellschaft Sachsen-Anhalt mbH is a private equity/ venture capital firm founded in 1996. The firm is headquartered in Magedeburg.
11
| Subsidiary | Investment Managers | 11 |
Market Logic Software AG
 Market Logic Software AG Packaged SoftwareTechnology Services Market Logic Software AG designs and develops enterprise business software for product management. Its software helps to manage research, search information, build knowledge, guide innovation, plan marketing and drive sales. The firm provides marketing information systems to the marketing and research teams. Its clients include global brands from FMCG and CPG, healthcare, retail, high-tech, finance and communications sectors and research agencies. The company was founded by Kay Iversen in 2006 and is headquartered in Berlin, Germany.
8
| Holding Company | Packaged Software | 8 |
Acktar Ltd.
 Acktar Ltd. Chemicals: Major DiversifiedProcess Industries Acktar Ltd. engages in the development, industrialization and production of black light absorbing coating. Its products include light absorbing foils, die-cuts solutions, optical components, black optical coatings, high specific surface area coatings, vacuum coater and high capacitance anode and cathode foils. The firm also offers coating services that include black optical coating and light absorbing foil. It serves the space, defense, semiconductor, solar energy and commercial industries. The company was founded in 1994 by Zvi Finkelstein and Dina Katsir and is headquartered in Kiryat-Gat, Israel.
2
| Holding Company | Chemicals: Major Diversified | 2 |
Elector GmbH
 Elector GmbH Financial ConglomeratesFinance Elector GmbH engages in the acquisition, holding, and management of participating interests in firms. The company was founded on November 20, 2012 and is headquartered in Berlin, Germany.
1
| Subsidiary | Financial Conglomerates | 1 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Dinnies Johannes von der Osten tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| MERCK KGAA | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| 4SC AG | Biotechnology | Chairman Chief Executive Officer | |
F-Star Biotechnologische Forschungs- Und Entwicklungsges MBH
 F-Star Biotechnologische Forschungs- Und Entwicklungsges MBH Medical SpecialtiesHealth Technology F-Star Biotechnologische Forschungs- Und Entwicklungsges MBH develops improved therapeutic antibodies and antibody fragments for cancer. It is a biopharmaceutical company dedicated to developing novel bispecific antibody products that significantly improve on the current standard of care for patients with serious diseases such as cancer. The firm's modular antibody technology allows them to rapidly discover and develop bispecific antibodies by introducing additional binding sites to the constant region of an antibody. The company was founded by Florian Ruker, Gordana Wozniak-Knopp, and Gottfried Himmler on June 12, 2006 and is headquartered in Vienna, Austria. | Medical Specialties | Director/Board Member | |
| NOVARTIS AG | Pharmaceuticals: Major | Public Communications Contact | |
TVM Capital GmbH
 TVM Capital GmbH Investment ManagersFinance TVM Capital GmbH (TVMC) is an international venture capital firm headquartered in Munich, Germany. Founded in 1983, the firm was formerly known as Techno Venture Management. | Investment Managers | Private Equity Investor Chairman | |
| EVOTEC SE | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| MORPHOSYS AG | Biotechnology | Human Resources Officer Public Communications Contact | |
Andera Partners SCA
 Andera Partners SCA Investment ManagersFinance Andera Partners SCA (Andera Partners) is a private equity firm founded in 2001 by Pierre-Michel Passy. The firm is headquartered in Paris, France. | Investment Managers | Private Equity Investor | |
NOXXON Pharma AG
 NOXXON Pharma AG BiotechnologyHealth Technology NOXXON Pharma AG operates a clinical stage biotechnology company. Its core focus is on cancer treatment. The firm offers effectiveness of cancer treatments including immuno-oncology approaches such as immune checkpoint inhibition and current standards of care such as chemotherapy and radiotherapy. The company was founded in 1997 by Sven Klussmann, Jens-Peter Fürste and Thomas Klein and is headquartered in Berlin, Germany. | Biotechnology | Chairman Chairman Director/Board Member | |
CFH Management GmbH
 CFH Management GmbH Investment ManagersFinance CFH Beteiligungsgesellschaft mbH (CFH) is the investment arm and a wholly-owned subsidiary Landesbank Baden-Württemberg. CFH was founded in 1996 and is headquartered in Leipzig on the eastern side of Germany. CFH manages private equity funds including regional funds focused on Saxony and venture capital funds. They also manage a portfolio of direct participations and a private equity fund of fund. In addition to their parent Sachsen Landesbank and the Government of Land Sachsen, their investors include large regional savings banks and European entities. | Investment Managers | Chief Investment Officer | |
Euronext Paris SA
 Euronext Paris SA Investment Banks/BrokersFinance Euronext Paris SA operates as a stock exchange which provides solutions for regulated stock and derivatives markets in France. Its services include facilitating public offerings, providing trading facilities for cash and derivatives products, and supplying market data. The company was founded on January 20, 1988 and is headquartered in Courbevoie, France. | Investment Banks/Brokers | Director/Board Member | |
Novoplant GmbH
 Novoplant GmbH Agricultural Commodities/MillingProcess Industries Novoplant GmbH develops and provides veterinary medicines. It produces antibodies and antibody fragments in plants for veterinary use to fight intestinal pathogens. It received a license for the development and commercialization of therapeutic antibodies as feed components for use in veterinary medicine. It will use MorphoSys’s HuCAL GOLD technology to generate antibodies against viruses, parasites and pathogenic microorganisms. The addition of such antibodies to animal feed stock may offer protection against infectious diseases in the respective animal’s gastro-intestinal tract. The company was founded in 1998 and is headquartered in Gatersleben, Germany. | Agricultural Commodities/Milling | Chairman | |
| Eberhard Karls Universität Tübingen | College/University | Undergraduate Degree | |
| SPEXIS AG | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| SUPERSONIC IMAGINE | Medical Specialties | Director/Board Member | |
| Ludwig-Maximilians-Universität München | College/University | Doctorate Degree Graduate Degree Doctorate Degree Undergraduate Degree | |
| Universität Leipzig | College/University | Doctorate Degree | |
Merck Serono SA
 Merck Serono SA Medical SpecialtiesHealth Technology Merck Serono SA operates as a holding company in the pharmaceutical field. It engages in the research, development, manufacture, and distribution of therapeutic products for the treatment of human diseases. The company was founded on May 21, 1987 and is headquartered in Coinsins, Switzerland. | Medical Specialties | Chief Tech/Sci/R&D Officer | |
Connecting for Health
 Connecting for Health Internet Software/ServicesTechnology Services Connecting for Health addresses the challenges of protected health information between sub-network organizations on a nationwide health information network. The company is headquartered in New York, NY. | Internet Software/Services | Corporate Officer/Principal | |
| Martin-Luther-Universität Halle-Wittenberg | College/University | Undergraduate Degree Doctorate Degree | |
JenaValve Technology GmbH
 JenaValve Technology GmbH Medical SpecialtiesHealth Technology JenaValve Technology GmbH develops and manufactures transcatheter valve implantation systems for transapical and transfemoral implantation. The firm offers a therapeutic alternative to surgical aortic valve replacement for high-risk patients suffering from aortic heart valve stenosis. The company was founded by Markus Ferrari, Volker Guyenot and Hans-Reiner Figulla in 2006 and is headquartered in Munich, Germany. | Medical Specialties | Director/Board Member | |
Ambu Innovation GmbH
 Ambu Innovation GmbH Medical SpecialtiesHealth Technology Ambu Innovation GmbH engages in the development and distribution of single-use and light-weight robotically-assisted high definition endoscopy products in the field of gastroenterology and gastro-intestinal surgery. Its products include invendoscope SC210, invendo ScopeController, and invendo SPU E210. The company was founded in 1992 and is headquartered in Kissing, Germany. | Medical Specialties | Director/Board Member | |
Novosom Verwaltungs GmbH
 Novosom Verwaltungs GmbH BiotechnologyHealth Technology Novosom Verwaltungs GmbH provides clinical development services and hospital equipment. It offers its own euqipment and technology to discover new methods of healing and researching on ribonucleic acid. The company was founded by Steffen Panzner in 1999 and is headquartered in Halle, Germany. | Biotechnology | Director/Board Member | |
Vakzine Projekt Management GmbH
 Vakzine Projekt Management GmbH Pharmaceuticals: MajorHealth Technology Vakzine Projekt Management GmbH develops vaccines and biopharmaceuticals products from laboratory stages through to clinical examination. It offers VPM2001 vaccine to prevent human cytomegalovirus infections and VPM5001 Soluferon vaccine, treatment for multiple sclerosis (MS) and hepatitis C. The company was founded in August 2002 and is headquartered in Hannover, Germany. | Pharmaceuticals: Major | General Counsel | |
| Julius-Maximilians-Universität Würzburg | College/University | Doctorate Degree | |
Sapiens Steering Brain Stimulation BV
 Sapiens Steering Brain Stimulation BV Electronic Equipment/InstrumentsElectronic Technology Sapiens Steering Brain Stimulation BV develops medical devices. The company was founded by Sjaak Deckers in 2011 and is headquartered in Eindhoven, the Netherlands. | Electronic Equipment/Instruments | Director/Board Member | |
bmp Ventures /Venture Capital/
 bmp Ventures /Venture Capital/ Investment ManagersFinance bmp Ventures /Venture Capital/ (bmp Ventures) is the venture capital arm of bmp Ventures AG. It was founded by Oliver Borrmann in 1997. The firm is headquartered in Berlin, Germany, with another German office located in Magdeburg. | Investment Managers | Private Equity Investor Private Equity Investor Private Equity Investor Private Equity Investor Private Equity Investor | |
Allecra Therapeutics GmbH
 Allecra Therapeutics GmbH Pharmaceuticals: MajorHealth Technology Allecra Therapeutics GmbH focuses on the development of novel treatments to combat multi drug-resistant bacterial infections. The firm serves the bio and pharmaceutical industry. The company was founded by Nicholas Benedict and Stuart Shapiro in 2013 and is headquartered in Weil am Rhein, Germany. | Pharmaceuticals: Major | Director/Board Member | |
| Harvard Business School | College/University | Undergraduate Degree Masters Business Admin | |
| The Fuqua School of Business | College/University | Masters Business Admin | |
OMEICOS Therapeutics GmbH
 OMEICOS Therapeutics GmbH BiotechnologyHealth Technology OMEICOS Therapeutics GmbH develops small molecules using endogenous protective mechanism for the treatment and prevention of atrial fibrillation. It operates as a biopharmaceutical company developing molecule therapeutics for the prevention and treatment of cardiovascular diseases including atrial fibrillation. The company was founded by Wolf-Hagen Schunck, John R. Falck, Dominik Müller, Robert Fischer and Karen Uhlmann in 2013 and is headquartered in Berlin, Germany. | Biotechnology | Chief Executive Officer | |
Ventaleon GmbH
 Ventaleon GmbH Pharmaceuticals: OtherHealth Technology Ventaleon GmbH is a biotechnology company, which engages in the development of inhaled treatments against viral infections. Its products include LASAG (D,L-lysine acetylsalicylate • glycine), a lysin-salt formulation of well known acetyl salicylic acid. The company was founded by Gerhard Scheuch in 2012 and is headquartered in Gauting, Germany. | Pharmaceuticals: Other | Director/Board Member Chief Executive Officer | |
| TME PHARMA N.V. | Biotechnology | Chairman Director/Board Member | |
Atriva Therapeutics GmbH
 Atriva Therapeutics GmbH BiotechnologyHealth Technology Atriva Therapeutics GmbH is a biopharmaceutical company that develops host-targeting antiviral therapies. It focuses on the development of new antiviral therapies against different respiratory viral infections. The company was founded by Rainer Lichtenberger and Henrik Luer Lueßen in April 2015 and is headquartered in Tuebingen, Germany. | Biotechnology | Director/Board Member | |
| ACER THERAPEUTICS INC. | Pharmaceuticals: Major | Director/Board Member | |
| INFLARX N.V. | Biotechnology | Director of Finance/CFO Director of Finance/CFO | |
| CENTOGENE N.V. | Miscellaneous Commercial Services | Director/Board Member | |
Vectura GmbH
 Vectura GmbH Medical SpecialtiesHealth Technology Vectura GmbH manufactures and develops pharmaceutical therapies for airways diseases. It offers dry powder formulation technology, device technology, and development capabilities. The company was founded by Gerhard Scheuch in 1997 and is headquartered in Gemünden, Germany. | Medical Specialties | Director/Board Member Corporate Officer/Principal | |
| Zeneca AGro Gmbh | Sales & Marketing | ||
MedNet GmbH
 MedNet GmbH Medical DistributorsDistribution Services MedNet GmbH provides standard and customized components for medical devices and other industries from a single source. The private company is based in Muenster, Germany. The CEOs are David Thaler, Inge Bröskamp. The German company was founded in 1990. | Medical Distributors | Corporate Officer/Principal |
Statistiche
Distribuzione geografica
| Germania | 33 |
| Stati Uniti | 7 |
| Francia | 6 |
| Svizzera | 5 |
| Austria | 2 |
Settori
| Health Technology | 29 |
| Consumer Services | 8 |
| Finance | 6 |
| Commercial Services | 4 |
| Distribution Services | 3 |
Posizioni
| Director/Board Member | 132 |
| Corporate Officer/Principal | 54 |
| Chairman | 38 |
| Private Equity Investor | 30 |
| Chief Executive Officer | 24 |
Contatti più connessi
| Insiders | |
|---|---|
| Jörg Neermann | 34 |
| Erich Maximilian Platzer | 31 |
| Hubert Birner | 27 |
| Claus Tycho Bræstrup | 27 |
| Olivier Litzka | 21 |
| Arnd Christ | 15 |
| Axel Polack | 12 |
| Cornelis Kees | 11 |
| Angelika Vlachou | 11 |
| Thomas van Aubel | 10 |
| Hendrik Liebers | 9 |
| Mark D. Booth | 8 |
| Arno Bohn | 8 |
| Ulrich Dauer | 7 |
| Maren Gerasch | 7 |
- Borsa valori
- Insiders
- Dinnies Johannes von der Osten
- Connessioni Società